MiR-135a Protects against Myocardial Injury by Targeting TLR4.

Feng, Hui; Xie, Bing; Zhang, Zhuoqi; Yan, Jun; Cheng, Mingyue; Zhou, Yafeng

Feng, Hui; Xie, Bing; Zhang, Zhuoqi; Yan, Jun; Cheng, Mingyue; Zhou, Yafeng.

Afiliação

Feng H; Department of Cardiology, The First Affiliated Hospital of Soochow University.
Xie B; Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University.
Zhang Z; Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University.
Yan J; Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University.
Cheng M; Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University.
Zhou Y; Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University.

Chem Pharm Bull (Tokyo) ; 69(6): 529-536, 2021.

Article em En | MEDLINE | ID: mdl-34078799

Assuntos

MicroRNAs/metabolismo; Miócitos Cardíacos/metabolismo; Receptor 4 Toll-Like/metabolismo; Animais; Apoptose; Células Cultivadas; Inflamação/metabolismo; Masculino; Camundongos; Camundongos Endogâmicos C57BL; MicroRNAs/genética; Miócitos Cardíacos/patologia

Palavras-chave

cardiac injury; miR-135a; myocardial infarction; toll-like receptor 4 (TLR4)

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Miócitos Cardíacos / MicroRNAs / Receptor 4 Toll-Like Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Chem Pharm Bull (Tokyo) Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google